| __timestamp | BioMarin Pharmaceutical Inc. | Merck & Co., Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 461543000 | 7180000000 |
| Thursday, January 1, 2015 | 634806000 | 6704000000 |
| Friday, January 1, 2016 | 661905000 | 7194000000 |
| Sunday, January 1, 2017 | 610753000 | 9982000000 |
| Monday, January 1, 2018 | 696328000 | 9752000000 |
| Tuesday, January 1, 2019 | 715007000 | 9872000000 |
| Wednesday, January 1, 2020 | 628116000 | 13397000000 |
| Friday, January 1, 2021 | 628793000 | 12245000000 |
| Saturday, January 1, 2022 | 649606000 | 13548000000 |
| Sunday, January 1, 2023 | 746773000 | 30531000000 |
| Monday, January 1, 2024 | 747184000 |
Unleashing insights
In the competitive world of pharmaceuticals, research and development (R&D) spending is a key indicator of innovation and future growth. Over the past decade, Merck & Co., Inc. and BioMarin Pharmaceutical Inc. have showcased contrasting strategies in their R&D investments. From 2014 to 2023, Merck's R&D expenses surged by over 300%, peaking at a staggering $30.5 billion in 2023. This reflects Merck's aggressive pursuit of groundbreaking treatments and therapies. In contrast, BioMarin's R&D spending grew by approximately 62%, reaching $746 million in 2023. While smaller in scale, BioMarin's focused investments highlight its commitment to niche markets and specialized therapies. This divergence in R&D strategies underscores the varied paths companies take to drive innovation and maintain competitive edges in the ever-evolving pharmaceutical landscape.
Johnson & Johnson vs Merck & Co., Inc.: Strategic Focus on R&D Spending
R&D Insights: How Merck & Co., Inc. and Zoetis Inc. Allocate Funds
Merck & Co., Inc. vs Biogen Inc.: Strategic Focus on R&D Spending
Merck & Co., Inc. and BioMarin Pharmaceutical Inc.: A Comprehensive Revenue Analysis
R&D Spending Showdown: Merck & Co., Inc. vs ACADIA Pharmaceuticals Inc.
Merck & Co., Inc. vs Travere Therapeutics, Inc.: Strategic Focus on R&D Spending
Research and Development Investment: Merck & Co., Inc. vs Evotec SE
Merck & Co., Inc. or MiMedx Group, Inc.: Who Invests More in Innovation?
Research and Development Investment: BioMarin Pharmaceutical Inc. vs Jazz Pharmaceuticals plc
Research and Development: Comparing Key Metrics for BioMarin Pharmaceutical Inc. and Viking Therapeutics, Inc.
R&D Spending Showdown: BioMarin Pharmaceutical Inc. vs CRISPR Therapeutics AG
Research and Development Expenses Breakdown: BioMarin Pharmaceutical Inc. vs Celldex Therapeutics, Inc.